Wound Management News

Pooled data from phase 2 and phase 3 studies suggest the efficacy and safety of Paratek Pharmaceutical’s investigational broad-spectrum antibiotic omadacycline is comparable to Zyvox in the treatment of complicated skin and skin structure infections in adults.

A study that used electronic bottle caps to record each time a pill bottle was opened showed that patients commonly overstated their adherence to antibiotic regimens for skin and soft tissue infections.

Patients who received a series of light-emitting diode low-level light therapy sessions after thyroidectomy showed improved scar quality compared with a control group, according to recent research.

Impavido, the only FDA-approved oral treatment for visceral, mucosal and cutaneous leishmaniasis, is now available in the United States, according to press release.

WASHINGTON – In a video perspective, Amy J. McMichael, MD, discusses research presented at the Skin of Color Society meeting.

WASHINGTON — The therapeutic vaccine candidate GEN-003 significantly reduced genital lesions and viral shedding in patients with genital herpes simplex virus-2, according to phase 2 data presented at the American Academy of Dermatology annual meeting.

WASHINGTON — In a video perspective from the American Academy of Dermatology Annual Meeting, Tina Alster, MD, discusses her presentation on laser scar revision.

Study results finding a link between Parkinson’s disease and melanoma was among the most-read news of February on Healio.com/Dermatology.

Young women who had bilateral reduction mammoplasty after ovulation had an increased risk for wound healing issues and hypertrophic scarring, according to recently published study results.

Prescription topical Bionect is available in the United States in a foam formula that will hold its shape until application, according to a press release from Cipher Pharmaceuticals.